Effect of Mother DHA Supplementation on Premature Newborn.
Multidisciplinary Study of the Effect of the Mother suplementación During the Lactation With High Doses of DHA on Diverse Aspects Related to the Development of the Premature Newborn in the First Year of Life.
1 other identifier
interventional
40
1 country
1
Brief Summary
To date, the investigations in the field of the supplementation with DHA in premature babies have been focused on the study of neuronal and visual development, giving place to contradictory and ambiguous results, because they did not consider in many cases important aspects of this supplementation, such as the mother´s diet, dose, duration, etc., and precise studies have not been performed in the field of the oxidative damage, inflammation and bone development in this population. Hypothesis: If the composition of the mother´s milk is modified on the basis of her diet, a mother supplementation with high doses of DHA will increase proportionally the levels of this fatty acid in her milk, fact that will allows the premature newborn child receive a major dose of this fatty acid, and therefore this way, we will manage to improve the neuronal and visual development and to take part on the inflammatory process, oxidative damage and its evolution, together with the development or bone mass increase in the premature baby. Aims: Overall we aim to evaluate in a multidisciplinary way the effect of a mother supplementation during the lactation with high doses of DHA on the development and wellness of the premature newborn children. We try to deepen into the effect on the neuronal and visual development and to study, for the first time, the effect on the oxidative damage, pro- and antiinflammatory citoquines activity and bone metabolism in this group of newborn babies.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for phase_2
Started Jan 2012
Typical duration for phase_2
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2013
CompletedFirst Submitted
Initial submission to the registry
September 3, 2013
CompletedFirst Posted
Study publicly available on registry
September 12, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2015
CompletedDecember 2, 2015
November 1, 2015
1.7 years
September 3, 2013
November 30, 2015
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
blood and milk samples
Assessment of oxidative stress
at delivery
Secondary Outcomes (1)
Blood
at delivery
Study Arms (2)
DHA supplementation
EXPERIMENTALmothers consuming 900 mg DHA/day and their neonates.
Control
ACTIVE COMPARATORfollow on capsules without probiotics
Interventions
We will establish two groups of premature newborn children (\<34 weeks) (n=40) and one group of newborn children to term (n=40). The mothers of one of the groups of premature newborn children will receive an oral supplementation by means of capsules with high dose of DHA (900 mg/day) during the lactation (minimum period of 3 months).
We will establish two groups of premature newborn children (\<34 weeks) (n=40) and one group of newborn children to term (n=40). The mothers of one of the groups of premature newborn children will receive an oral supplementation by means of capsules with high dose of DHA during the lactation (minimum period of 3 months).
Eligibility Criteria
You may qualify if:
- Preterm neonate, gestational age 30-34, PAEG (\>P10, \<P95), no pathologies.
You may not qualify if:
- Lactose intolerance, systemic illness, multiple gestation, cromosomopathies, antibacterial therapy.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Hospital San Cecilio
Granada, Granada, 18071, Spain
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Julio J Ochoa, Ph.D.
Universidad de Granada
Study Design
- Study Type
- interventional
- Phase
- phase 2
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Julio J. Ochoa
Study Record Dates
First Submitted
September 3, 2013
First Posted
September 12, 2013
Study Start
January 1, 2012
Primary Completion
September 1, 2013
Study Completion
November 1, 2015
Last Updated
December 2, 2015
Record last verified: 2015-11